ACTRN12622000074796Not yet recruiting未知
Pharmacokinetics of high dose quercetin – a potential treatment for adults with asthma
eon Huang0 sites30 target enrollmentStarted: January 21, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •1.Age greater than or equal to 18 years
- •2.Able to provide informed consent
- •3.Body mass index 18.0 – 35.0 kg/m2
Exclusion Criteria
- •1.Participants with chronic kidney disease with eGFR < 30
- •2.Participants with evidence of active or suspected cancer and participants having undergone cancer treatment including resection, radiation therapy or chemotherapy within the last 2 years (participants with basal cell carcinoma and squamous cell carcinoma are allowed)
- •3.Participation in a separate clinical or device trial within 4 weeks of screening
- •4.Participants currently taking cyclosporine, pravastatin, fexofenadine, and/or midazolam
- •5.Pregnant or lactating women
- •6.Allergy to quercetin
Investigators
Similar Trials
Not yet recruiting
Phase 2
Research on Quercetin Extracts: Studying Their Effects in Healthy PeopleCTRI/2024/01/061470Tilman SA
Completed
Not Applicable
Pharmacokinetic of quercetin in tears following oral ingestiodry eye diseaseJPRN-UMIN000037092Tokyo Dental College10
Completed
Phase 2
Quercetin in thalassemiabeta thalassemia major.Cooley anaemia Severe beta thalassaemia Thalassaemia: intermedia majorIRCT201701172709N43Vice chancellor for research, Iran University of Medical Sciences84
Completed
Not Applicable
Effect of co-administration of quercetin on the endothelial dysfunction after continuous treatment of nitroglycerin in Japanese volunteers with aldehyde dehydrogenase2 *2 polymorphism: randomized crossover trialangina pectorisJPRN-UMIN000033639SOUSEIKAI Fukuoka Mirai Hospital, Clinical Research Center24
Completed
Unknown
Effects of quercetin ingestion during 6 weeks of strength training on neuromuscular activity in the older adults.JPRN-UMIN000053019Chukyo University30